Financial Technology

Financial Technology - INDUSTRY NEWS


TMCNet:  Stock to Watch: Cardium Therapeutics Up 6.5% (CXM)

[January 03, 2013]

Stock to Watch: Cardium Therapeutics Up 6.5% (CXM)

Jan 03, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Cardium Therapeutics (AMEX:CXM) is one of today's best performing penny stocks, up 6.5% to $0.21 on 2.3x average daily volume. Thus far today, Cardium Therapeutics has traded 538,000 shares, vs. average volume of 232,000 shares per day. The stock has outperformed the Dow (7.9% to the Dow's 0.1%) and outperformed the S&P 500 (7.9% to the S&P's 0.2%) during today's trading.
Story continues below ↓

Cardium Therapeutics Inc. is an interventional cardiology company. The Company focuses on late-stage clinical development and commercialization of DNA-based growth factor therapeutics as treatments for coronary artery disease and heart attack.

Cardium Therapeutics has overhead space with shares priced $0.20, or 59.0% below the average consensus analyst price target of $0.50. Cardium Therapeutics shares should encounter resistance at the 200-day moving average (MA) of $0.23 and support at the 50-day MA of $0.20.

In the past 52 weeks, Cardium Therapeutics share prices have been bracketed by a low of $0.17 and a high of $0.42 and are now at $0.20, 21% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.6% while the 200-day MA has slid 0.6%.

SmarTrend recommended that its subscribers protect gains by selling shares of Cardium Therapeutics on April 9th, 2012 by issuing a Downtrend alert when the shares were trading at $0.25. Since that call, shares of Cardium Therapeutics have fallen 22.4%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To Financial Technology's Homepage ]